» Articles » PMID: 18431843

The C-Jun N-terminal Kinase JNK Functions Upstream of Aurora B to Promote Entry into Mitosis

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2008 Apr 24
PMID 18431843
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Mitogen-activated protein kinases (MAPKs) are components of signaling cascades regulated by environmental stimuli. In addition to participating in the stress response, the MAPKs c-Jun N-terminal Kinases JNK1 and JNK2 regulate the proliferation of normal and neoplastic cells. JNKs contribute to these processes largely by phosphorylating c-Jun and thus contributing to the activation of the AP-1 complex. We here report that JNKs control entry into mitosis. We have observed that JNK activity and phosphorylation of c-Jun become elevated during the G2/M transition of the cell cycle in immortalized fibroblasts and ovarian granulosa cells. Pharmacological inhibition of JNK causes a profound cell cycle arrest at the G2/M transition in both cell types. This effect is specific as it occurs with two distinct small molecule compounds. Inactivation of JNK prior to mitosis prevents expression of Aurora B and phosphorylation of Histone-H3 at Ser 10. Silencing of JNK1 and 2 causes a similar effect, whereas overexpression of JNK1 and 2 causes the opposite effect. Inhibition of JNK delays activation of cdc-2 and prevents downregulation of Cyclin B1. We conclude that JNK signaling promotes entry into mitosis by promoting expression of Aurora B and thereby phosphorylation of Histone-H3.

Citing Articles

Loss of Cdc42 causes abnormal optic cup morphogenesis and microphthalmia in mouse.

Hofstetter K, Haas P, Kuntz J, Zheng Y, Fuhrmann S Front Cell Neurosci. 2024; 18:1474010.

PMID: 39650797 PMC: 11622195. DOI: 10.3389/fncel.2024.1474010.


Loss of Cdc42 causes abnormal optic cup morphogenesis and microphthalmia in mouse.

Hofstetter K, Haas P, Kuntz J, Zheng Y, Fuhrmann S bioRxiv. 2024; .

PMID: 39484575 PMC: 11526912. DOI: 10.1101/2024.10.20.619331.


Combination Inhibition with the Multitargeting Tyrosine Kinase Inhibitor Axitinib Shows Additive Anticancer Activity in -Mutant Anaplastic Thyroid Cancer.

Gunda V, Ghosh C, Hu J, Zhang L, Zhang Y, Shen M Thyroid. 2023; 33(10):1201-1214.

PMID: 37675898 PMC: 10625471. DOI: 10.1089/thy.2023.0201.


Pathophysiological Significance of WDR62 and JNK Signaling in Human Diseases.

Zhi Y, Zhou X, Yu J, Yuan L, Zhang H, Ng D Front Cell Dev Biol. 2021; 9:640753.

PMID: 33937237 PMC: 8086514. DOI: 10.3389/fcell.2021.640753.


FOXD1 regulates cell division in clear cell renal cell carcinoma.

Bond K, Fetting J, Lary C, Emery I, Oxburgh L BMC Cancer. 2021; 21(1):312.

PMID: 33761914 PMC: 7988646. DOI: 10.1186/s12885-021-07957-8.